X4 Pharmaceuticals Inc.

NASDAQ: XFOR · Real-Time Price · USD
2.84
-0.30 (-9.55%)
At close: Aug 15, 2025, 3:59 PM
2.80
-1.41%
After-hours: Aug 15, 2025, 07:54 PM EDT

X4 Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-101.98M 14.6M -37.45M -16.76M 17.63M -128.91M -132.86M -137.75M -164.55M -130.05M -96.3M -102.49M -93.56M -91.98M -88.7M -76.89M -74.16M -69.67M
Depreciation & Amortization
1.37M 1.21M 796K 585K 422K 354K 418K 483K 503K 509K 516K 521K 529K 526K 499K 470K 484K 421K
Stock-Based Compensation
5.3M 6.98M 8.2M 8.53M 9.07M 8.78M 8.69M 7.25M 6M 5.38M 5.2M 5.7M 6.11M 6.38M 6.18M 5.97M 6.7M 6.07M
Other Working Capital
-5.88M -3.83M 4.3M -3.36M -1.78M -1.13M -573K 7.31M 8.58M 6.51M 4.28M -622K 1.41M -551K -2.66M -4.67M -8.09M -5.05M
Other Non-Cash Items
-4.57M -128.29M -103.65M -110.79M -113.87M 43.65M 62.11M 61.24M 63.91M 31.56M -738K 4.76M 2.27M 5.63M 5.78M 11.78M 11.18M 9.67M
Deferred Income Tax
n/a n/a n/a -1.85M -27.02M -29.29M -31.55M -29.7M -4.54M -2.27M n/a 10.12M 10.12M 6.83M 6.83M -9.23M -9.23M -7.99M
Change in Working Capital
-9.43M -4.17M 1.2M -5.36M 1.32M 1.82M 1.27M 7.25M 9.18M 8.33M 6.48M 4.54M 2.56M -75K -1.5M -1.45M -4.44M -239K
Operating Cash Flow
-109.3M -109.67M -130.9M -125.65M -112.45M -103.6M -91.42M -90.19M -88.45M -85.5M -84.31M -76.85M -71.97M -72.69M -70.91M -69.36M -69.47M -61.73M
Capital Expenditures
-3.13M -3.27M -326K -320K -236K -110K -59K -33K -59K -89K -103K -107K -93K -141K -615K -904K -1.38M -1.3M
Cash Acquisitions
n/a n/a n/a 4.8K -995.2K -995.2K -995.2K -1M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-60.82M -58.76M -57.13M -40.15M -25.21M -27.09M -16.82M -15.83M -14.48M -9.6M -9.6M -4.8M n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
59.38M 33.2M 26.45M 13.25M 9M 7M 2M 1M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a 98M 98M 98M 99M 990.33K -3.89M 921.12K 4.72M 4.73M 9.58M 4.78M -22K -22K -496K -496K -496K -496K
Investing Cash Flow
-4.58M 69.17M 66.99M 70.78M 81.55M -20.2M -19.76M -14.93M -9.81M -4.96M -103K -107K -93K -141K -615K -904K -1.38M -1.3M
Debt Repayment
-20M n/a n/a 20M 41.74M 22.12M 20.44M 20.44M -861K -1.57M -795K -795K -1.23M -909K n/a 7.5M 7.5M 7.5M
Common Stock Repurchased
46K n/a n/a n/a n/a 443K n/a n/a n/a -443K n/a n/a -4.44K -5.37K -5.37K 30.63K -228.92K -228.01K
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
20.14M 20.14M 20.14M -159K n/a 8.23M 8.23M 8.23M 8.23M n/a -12K 91K 91K 207K 260K 250K 230K 179K
Financial Cash Flow
5.77M 20.29M 20.29M 20.26M 41.46M 90.64M 159.98M 157.76M 197.2M 127.51M 63.13M 89.82M 24.74M 24.16M 74.25M 57.3M 61.46M 62.45M
Net Cash Flow
-107.97M -20.23M -43.77M -34.41M 10.54M -33.17M 48.83M 52.6M 99.33M 37.25M -21.14M 12.84M -47.81M -48.92M 2.41M -13M -9.15M -294K
Free Cash Flow
-112.43M -112.94M -131.23M -125.97M -112.69M -103.71M -91.48M -90.22M -88.51M -85.59M -84.41M -76.96M -72.06M -72.83M -71.52M -70.26M -70.85M -63.04M